The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000051.4(ATM):c.3102T>G (p.Tyr1034Ter)

CA382515111

556315 (ClinVar)

Gene: ATM
Condition: hereditary breast cancer
Inheritance Mode: Autosomal dominant inheritance
UUID: 756acc7f-cc37-4f6f-92d4-f2a193bcab5b
Approved on: 2024-01-25
Published on: 2024-02-14

HGVS expressions

NM_000051.4:c.3102T>G
NM_000051.4(ATM):c.3102T>G (p.Tyr1034Ter)
NC_000011.10:g.108272556T>G
CM000673.2:g.108272556T>G
NC_000011.9:g.108143283T>G
CM000673.1:g.108143283T>G
NC_000011.8:g.107648493T>G
NG_009830.1:g.54725T>G
ENST00000452508.7:c.3102T>G
ENST00000713593.1:c.*2573T>G
ENST00000278616.9:c.3102T>G
ENST00000683174.1:n.3252T>G
ENST00000527805.6:c.3102T>G
ENST00000675595.1:c.2937T>G
ENST00000675843.1:c.3102T>G
ENST00000278616.8:c.3102T>G
ENST00000452508.6:c.3102T>G
ENST00000527805.5:c.3102T>G
NM_000051.3:c.3102T>G
NM_001351834.1:c.3102T>G
NM_001351834.2:c.3102T>G
More

Pathogenic

Met criteria codes 4
PM5_Supporting PM2_Supporting PVS1 PM3_Strong

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Hereditary Breast, Ovarian and Pancreatic Cancer Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for ATM Version 1.2.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Hereditary Breast, Ovarian and Pancreatic Cancer VCEP
The c.3102T>G (p.Tyr1034Ter) variant in ATM is a nonsense variant predicted to cause a premature stop codon in a biologically-relevant-exon leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism. This alteration results in a termination codon upstream of the most C-terminal pathogenic alteration (ATM p.Arg3047*), as classified by the HBOP VCEP, and is expected to be more deleterious. This variant is absent from gnomAD v.2.1.1. This variant has been detected in at least 4 individuals with Ataxia-Telangiectasia (PMID: 26896183, 18321536, 33547824). In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant hereditary breast cancer and autosomal recessive Ataxia-Telangiectasia based on the ACMG/AMP criteria applied, as specified by the HBOP VCEP. (PVS1, PM3_strong, PM2_Supporting , PM5_Supporting)
Met criteria codes
PM5_Supporting
This alteration results in a termination codon upstream of the most C-terminal pathogenic alteration (ATM p.Arg3047*), as classified by the HBOP VCEP, and is expected to be more deleterious (PM5_Supporting).
PM2_Supporting
This variant is absent from gnomAD v.2.1.1 (PM2_Supporting).
PVS1
This variant is predicted to create an NMD-escaping transcript resulting in a loss of part of the HEAT repeat domain (PVS1).
PM3_Strong
This variant has been detected in 4 unrelated individuals with Ataxia-Telangiectasia (PM3_strong; PMID: 26896183, 18321536, 33547824).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.